Stalfort John A III - Insider Non-Derivative Transactions at Taysha Gene Therapies, Inc. (TSHA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 29, 2024, Stalfort John A III's relationship to Taysha Gene Therapies, Inc. (TSHA) is Director, and currently has 1,098,601 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TSHA insiders.
Data Source: SEC.
Stalfort John A III - Insider Non-Derivative Transactions of TSHA Common Stock
Stalfort John A III - Insider Non-Derivative Transactions at TSHA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 30, 2024 | Acquisition -- (Common Stock) | 49220 | 0 | 1098601 |
| Aug 17, 2023 | P -- (Common Stock) | 388889 | 0.9 | 884290 |
| Aug 17, 2023 | P -- (Common Stock) | 388889 | 0.9 | 999381 |
| Aug 17, 2023 | G -- (Common Stock) | 50000 | 0 | 1049381 |